Paraic Kenny, PhD, Gundersen Medical Foundation, La Crosse, WI, discusses the role of next-generation sequencing (NGS) in determining the optimal treatment pathway for patients with breast cancer. NGS enables molecular subtypes to be determined in patients, resulting in personalized therapies that can subsequently enhance survival outcomes. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.